Agenus





Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Celldex Therapeutics USD -86.34M 13.54M 2025-12
CSL USD 3.13B 1.17B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Incyte USD 414.5M 92.42M 2025-12
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 9.52B 389M 2025-09
Jiangsu Hengrui CNY 2.98B 890.87M 2025-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD 21.95M 55.39M 2025-09
Merck EUR 1.46B 45M 2025-06
Merck USD 8.39B 1.97B 2025-09
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Novartis USD 5.88B 290M 2025-09
Novavax USD -117.12M 55.66M 2024-09
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Veracyte USD 42.31M 2.58M 2025-12


Agenus - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.